INBRX-111

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameINBRX-111
Drug Alias NameINBRX-111
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInhibrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInhibrx Inc
Active IndicationsN/A
Inactive IndicationsPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A